Status:

RECRUITING

SPECT/CT Bone Scan Quantification Surgery

Lead Sponsor:

Central Hospital, Nancy, France

Conditions:

Pseudoarthrosis of Bone

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The hypothesis of our study is that SPECT/CT bone scan fixation quantified by SUVMAX on a CZT solid state camera preoperatively would identify good responders to lumbar arthrodesis surgery.

Detailed Description

Chronic low back pain is a public health problem and is the leading cause of work stoppage and the management of low back pain refractory to medical treatment involves surgical procedures such as arth...

Eligibility Criteria

Inclusion

  • Persons with back pain for at least 3 months (presumed to be due to degenerative disc disease or spondylolisthesis).
  • Persons who have received full information about the organisation of the research and have signed the informed consent and :
  • Age ≥ 18 years, having read and understood the information document.
  • Affiliated to a social security scheme.
  • Lumbar arthrodesis involving a maximum of 2 floors.
  • Standardized lumbar arthrodesis surgery performed by one of the three senior neurosurgeons of the neurosurgery department of the Nancy CHRU, using similar surgical techniques.

Exclusion

  • Low back pain of neuropathic origin. The Neuropathic Pain Scale 4 questionnaire is used to diagnose neuropathic pain (score is ≥ 4/10)
  • History of lumbar spine surgery
  • Presence of other pathologies responsible for lumbar pain (multistage discopathies, ankylosing spondylitis, spondylodiscitis, rheumatoid arthritis, vertebral compression, vertebral metastasis, narrow lumbar canal, scoliosis, spondylolisthesis by isthmic lysis)
  • Pregnant women or women of childbearing age without suitable contraception or nursing mothers.
  • Unstable medical condition and/or inability to remain immobile in supine position during recordings.
  • Known allergy to any component of the radiopharmaceutical (TECHNESCAN HDP).
  • Person referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code.
  • Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care by virtue of Articles L. 3212-1 and L. 3213-1.
  • Persons of full age who are unable to express their opposition.

Key Trial Info

Start Date :

April 29 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 29 2025

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT05183542

Start Date

April 29 2022

End Date

November 29 2025

Last Update

January 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Nuclear Medicine Department

Vandœuvre-lès-Nancy, France, 54511